SCHEMBL8616710

SCHEMBL8616710

Ic1ccc2c(c1)N(Cc1ccccc1)CC2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.48
SLC22A12 Q96S37 1/20 0.43
DDB1 Q16531 1/20 0.43
CRBN Q96SW2 1/20 0.43
ALDH1A1 P00352 2/20 0.42
AKR1B10 O60218 1/20 0.42
AKR1A1 P14550 1/20 0.42
AKR1B1 P15121 1/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
CDK4 P11802 1/20 0.42
ALOX15 P16050 1/20 0.42
CCND1 P24385 1/20 0.42
KMT2A Q03164 1/20 0.42
GRM5 P41594 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
GAA P10253 1/20 0.40
ALOX5 P09917 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18106575 0.81 HDAC1 (0.53) ACHESLC22A12DDB1CRBNALDH1A1
SCHEMBL16030871 0.81 CYP1A2 (0.55) ACHESLC22A12DDB1CRBNALDH1A1
SCHEMBL118883 0.81 HDAC1 (0.53) ACHESLC22A12DDB1CRBNALDH1A1
SCHEMBL2001003 0.81 ACHE (0.48) ACHESLC22A12DDB1CRBNALDH1A1
Hydrochloric Acid SCHEMBL28914132 0.80 ACHE (0.47) ACHESLC22A12DDB1CRBNALDH1A1
SCHEMBL29558 0.80 ALDH1A1 (0.66) DDB1CRBNALDH1A1MEN1USP2
SCHEMBL29875634 0.80 ALDH1A1 (0.66) DDB1CRBNALDH1A1MEN1USP2
SCHEMBL8490913 0.78 ACHE (0.48) ACHESLC22A12ALDH1A1HDAC1HDAC6
SCHEMBL6177893 0.78 ACHE (0.63) ACHESLC22A12ALDH1A1AKR1B10AKR1A1
SCHEMBL21635502 0.77 HTR2C (0.42) SLC22A12ALDH1A1MEN1USP2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998050346-A2 ACETAMIDE AND UREA DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 WO disclosed